Hypoxic breast cancer-derived exosomal miR-210 was proved to escalate into adjacent cells in the tumor microenvironment, promoting angiogenesis and metastasis in recipient cells by targeting Ephrin A3 and PTP1B, which are vascular remodeling-related genes [33]. The gene discussed is EFNA3; the disease is breast cancer.